Effect of Intravenous Lignocaine Infusion on Intraoperative End Tidal Desflurane Concentration Requirements

NACompletedINTERVENTIONAL
Enrollment

48

Participants

Timeline

Start Date

January 21, 2021

Primary Completion Date

November 19, 2021

Study Completion Date

November 19, 2021

Conditions
CholelithiasesAppendicitisOvarian Cysts
Interventions
DRUG

Lignocaine

IV bolus of 1.5 mg/kg of lignocaine 2% diluted in 10 ml syringe over 3 mins followed by infusion at 1 mg/kg/h of lignocaine 2% in 20 ml syringe

DRUG

Placebo

IV bolus of 10 ml normal saline over 3 min followed by infusion of equal volume of normal saline in 20 ml syringe

Trial Locations (1)

56000

Pusat Perubatan Universiti Kebangsaan Malaysia, Kuala Lumpur

All Listed Sponsors
lead

Universiti Kebangsaan Malaysia Medical Centre

OTHER

NCT06064331 - Effect of Intravenous Lignocaine Infusion on Intraoperative End Tidal Desflurane Concentration Requirements | Biotech Hunter | Biotech Hunter